Jong-Gu Kang
Chief Executive Officer chez BIOTOXTECH CO., LTD.
Fortune : 9 M $ au 31/03/2024
Profil
Jong-Gu Kang is currently the Chairman & Chief Executive Officer at Biotoxtech Co., Ltd., the Co-Chief Executive Officer at Scas-BTT Bioanalysis Co., Ltd., the Chief Executive Officer at Tru Technologies Ltd., the Chief Executive Officer & Director at Keyfron Bio Co., Ltd., and the Director at Korean Association For Laboratory Animal Science.
He started his career in 1990 as a Professor at Chungbuk National University.
He has also held positions as the Chief Executive Officer at Sejong Venture Partners Co., Ltd.
and as a Non-Executive Director at ENZYCHEM LIFESCIENCES Corp.
Dr. Kang holds a doctorate degree from the University of Tokyo and undergraduate and graduate degrees from Seoul National University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOTOXTECH CO., LTD.
12,76% | 29/03/2024 | 2 035 965 ( 12,76% ) | 9 M $ | 31/03/2024 |
Postes actifs de Jong-Gu Kang
| Sociétés | Poste | Début |
|---|---|---|
| BIOTOXTECH CO., LTD. | Chief Executive Officer | 01/01/2000 |
| Chungbuk National University | Corporate Officer/Principal | 30/05/2011 |
Scas-BTT Bioanalysis Co., Ltd.
 Scas-BTT Bioanalysis Co., Ltd. Scas-BTT Bioanalysis Co., Ltd. is engaged in Testing and Analysis Services of Composition and Purity of Materials. The company was founded on May 2, 2011 and is headquartered in Cheongju, South Korea. | Chief Executive Officer | - |
| Korean Association For Laboratory Animal Science | Director/Board Member | - |
Tru Technologies Ltd.
 Tru Technologies Ltd. Packaged SoftwareTechnology Services Tru Technologies Ltd. develops and operates securities finance software solutions. The company is based in Seoul, South Korea. The CEOs are Jae-Woo Ha, Jong-Gu Kang. The South Korean company was founded in 2019. | Chief Executive Officer | - |
| Keyfron Bio Co., Ltd. | Chief Executive Officer | - |
Anciens postes connus de Jong-Gu Kang
| Sociétés | Poste | Fin |
|---|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Director/Board Member | - |
Sejong Venture Partners Co., Ltd.
 Sejong Venture Partners Co., Ltd. Investment ManagersFinance Sejong Venture Partners Co Ltd (Sejong Venture) is a venture capital firm founded in 2013. The firm is headquartered in Seoul, South Korea. | Chief Executive Officer | - |
Formation de Jong-Gu Kang
| University of Tokyo | Doctorate Degree |
| Seoul National University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Health Technology |
| BIOTOXTECH CO., LTD. | Commercial Services |
| Entreprise privées | 5 |
|---|---|
Scas-BTT Bioanalysis Co., Ltd.
Scas-BTT Bioanalysis Co., Ltd. Scas-BTT Bioanalysis Co., Ltd. is engaged in Testing and Analysis Services of Composition and Purity of Materials. The company was founded on May 2, 2011 and is headquartered in Cheongju, South Korea. | |
Sejong Venture Partners Co., Ltd.
Sejong Venture Partners Co., Ltd. Investment ManagersFinance Sejong Venture Partners Co Ltd (Sejong Venture) is a venture capital firm founded in 2013. The firm is headquartered in Seoul, South Korea. | Finance |
| Korean Association For Laboratory Animal Science | |
Tru Technologies Ltd.
Tru Technologies Ltd. Packaged SoftwareTechnology Services Tru Technologies Ltd. develops and operates securities finance software solutions. The company is based in Seoul, South Korea. The CEOs are Jae-Woo Ha, Jong-Gu Kang. The South Korean company was founded in 2019. | Technology Services |
| Keyfron Bio Co., Ltd. |
